about
HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretionMolecular Mechanisms of Induction of Tolerant and Tolerogenic Intestinal Dendritic Cells in MiceRecombinant Lactococcus lactis can make the difference in antigen-specific immune tolerance induction, the Type 1 Diabetes caseZinc Status and Risk of Cardiovascular Diseases and Type 2 Diabetes Mellitus-A Systematic Review of Prospective Cohort Studies.Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation.Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitusPersistent circulating human insulin in sheep transplanted in utero with human mesenchymal stem cells.Integrative analysis of the transcriptome profiles observed in type 1, type 2 and gestational diabetes mellitus reveals the role of inflammationToxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice.Characterization of CD4+ T cells specific for glutamic acid decarboxylase (GAD65) and proinsulin in a patient with stiff-person syndrome but without type 1 diabetes.Design, implementation, and evaluation of a pediatric and adolescent type 2 diabetes management program at a tertiary pediatric center.Baicalein Protects against Type 2 Diabetes via Promoting Islet β-Cell Function in Obese Diabetic Mice.Population-based cohort study of anti-infective medication use before and after the onset of type 1 diabetes in children and adolescents.Huo-Luo-Xiao-Ling Dan modulates antigen-directed immune response in adjuvant-induced inflammation.Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse.Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes.Antigen-based vs. systemic immunomodulation in type 1 diabetes: the pros and cons.Danish children born with glutamic acid decarboxylase-65 and islet antigen-2 autoantibodies at birth had an increased risk to develop type 1 diabetesEfferocytosis promotes suppressive effects on dendritic cells through prostaglandin E2 production in the context of autoimmunity.Cognitive dysfunction associated with anti-glutamic acid decarboxylase autoimmunity: a case-control study.The epigenetics of autoimmunity.C3d adjuvant effects are mediated through the activation of C3d-specific autoreactive T cellsContribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.Immunosuppressive effects of streptozotocin-induced diabetes result in absolute lymphopenia and a relative increase of T regulatory cells.Proteomic Analysis of Disease Stratified Human Pancreas Tissue Indicates Unique Signature of Type 1 DiabetesChronic Endotoxemia in Subjects with Type-1 Diabetes Is Seen Much before the Onset of Microvascular Complications.Comprehensive Survey of miRNA-mRNA Interactions Reveals That Ccr7 and Cd247 (CD3 zeta) are Posttranscriptionally Controlled in Pancreas Infiltrating T Lymphocytes of Non-Obese Diabetic (NOD) Mice.Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function.Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes.Combination of double negative T cells and anti-thymocyte serum reverses type 1 diabetes in NOD micePrediction of type 1 diabetesFecal microbiota composition differs between children with β-cell autoimmunity and those without.Analyses of regulatory CD4+ CD25+ FOXP3+ T cells and observations from peripheral T cell subpopulation markers during the development of type 1 diabetes in children.Association of type 1 diabetes mellitus and autoimmune disorders in Brazilian children and adolescents.Positivity for Zinc Transporter 8 Autoantibodies at Diagnosis Is Subsequently Associated With Reduced β-Cell Function and Higher Exogenous Insulin Requirement in Children and Adolescents With Type 1 Diabetes.Review series on helminths, immune modulation and the hygiene hypothesis: how might infection modulate the onset of type 1 diabetes?A cell-based approach for diabetes treatment using engineered non-beta cells.GAD autoantibody epitope pattern after GAD-alum treatment in children and adolescents with type 1 diabetes.NF-κB and STAT1 control CXCL1 and CXCL2 gene transcription.Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes.
P2860
Q24299570-3E139C13-3309-4E82-B001-5E4D53EE5D59Q26765030-5C148FF6-F664-4C3A-AAFA-E98CCC7606C8Q27028100-30B94B3A-9977-4159-93D8-800850202E97Q30241575-02286623-6CD7-4F9B-B46E-9DFF6D37289FQ30430008-28F9FD2B-80E1-4A1D-84AB-667EBDBC06A0Q33576368-22EF69BE-28BF-40EE-8786-72E9D79F8509Q33787406-1E0FE90E-FE95-445A-9321-B77FBFFC4D87Q33789205-BDD3C648-D6E4-46BC-BE98-BC15C9F55E43Q33844333-D40B3263-F18A-4E85-A95E-649379361453Q33884262-91AC85BB-4F0C-4ABB-A728-154AB22B12CEQ34011958-9E92DEC2-C055-4A68-95EA-26F97C661FC7Q34043054-7AFD601B-6330-4F53-A83D-2D0880D4F480Q34058260-E66E2A8C-6C35-4C32-9275-02996152CB25Q34077846-48F39FE9-EFA3-4BBF-85F0-C3925A288427Q34182775-AA4DF0BA-5592-4978-913F-D8A951325C3DQ34341897-6BDAC61E-3CE7-4A52-9FE9-0F04AD24E5D6Q34375578-3181F269-6EB3-427A-8F73-34BE02A60083Q34497669-CD9D651A-BD2E-4435-B175-72EBA4B4FE2FQ34730167-A66D9816-FBAF-422C-9FD3-B7F756834769Q34802779-7485A022-1184-416A-BB80-1F14080B0F28Q34979322-081D40A1-AD00-4456-8143-7B1F965A64F1Q35071379-4CB5CADC-04C9-43C6-A77C-79F905FBAB24Q35123421-5A46D18E-3F92-4305-97DB-9F5744830366Q35179994-01D2E2BF-8D93-4D29-A88A-C2E53CDA5BC2Q35753856-9C2ECF23-2425-49DE-ADF1-5E17907C032EQ35773292-4938BB6D-0CC3-4706-BC13-BA7D352E24DAQ35852428-35C38334-A669-48CA-8260-80D6C5208A5DQ36182476-28617515-88E8-46C9-B06D-BF55C6F7976DQ36547660-0E00E9E5-C586-4793-8E99-8248D3F764D4Q36611514-EBB5D506-AF2D-4F2D-A288-61D25618BE83Q36720573-675C6375-346E-4469-B9F7-A3503DDB30FDQ36720600-432CE23A-AA42-4F8B-BEA0-A777D66F40E7Q36762700-2C91A013-786C-467D-A9B6-71A00BF54716Q36867469-B207135A-C66D-40FD-B237-7D9604396B04Q36926297-3D49986C-5BC1-4A78-AEC8-1045FDF0AF83Q37361478-3E5C6BE0-2E19-4CB2-A804-E056C1188B6DQ37404417-473D30D5-4120-4ED9-BAD4-59A45358667CQ37520366-82734A75-76D5-4ED8-BDE0-487FF73F985EQ37575397-F3AAECBB-0228-436F-9303-AD7DBBDA67A7Q37603286-A5FFBC70-4EE4-4792-A47D-F37987193E6B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Autoimmune mechanisms in type 1 diabetes.
@en
Autoimmune mechanisms in type 1 diabetes.
@nl
type
label
Autoimmune mechanisms in type 1 diabetes.
@en
Autoimmune mechanisms in type 1 diabetes.
@nl
prefLabel
Autoimmune mechanisms in type 1 diabetes.
@en
Autoimmune mechanisms in type 1 diabetes.
@nl
P1433
P1476
Autoimmune mechanisms in type 1 diabetes.
@en
P304
P356
10.1016/J.AUTREV.2008.04.008
P577
2008-04-30T00:00:00Z